One again illustrating the seemingly inextricable link between the burgeoning mHealth (mobile health) industry and Apple's iDevices, this week a company named Withings (a French start-up that concentrates on designing, developing, and industrializing connected devices) announced that the FDA has cleared the way for it's iOS blood pressure monitor. And the product has begun shipping to various retail outlets in the US.
Based on the language presented in FDA’s formal clearance, “The Withings Blood Pressure Monitor... is a noninvasive blood pressure measurement [system] intended to measure the systolic and diastolic blood pressures and pulse rate of an adult individual, over age 18, at home by using a non-invasive technique in which an inflatable cuff is wrapped around the upper arm."
Demonstrated earlier this year at the Consumer Electronics Show, this mobile BP monitor ($129.99) requires three AAA batteries and works like a charm with your iPhone, iPad or iPod Touch. Testing is accomplished via a free iOS app, which provides blood pressure reading results approximately thirty seconds after the test is initiated.
With more than 25% of the world’s population affected by hypertension, Withings has combined advanced technology and sophisticated design to create a medical device that is visually attractive, accurate and easy to use at home, in a professional setting or on the go. Cédric Hutchings, Withings co-founder says, “Apple has revolutionized the smartphone and tablet market with both its design and functionality. We have strived to extend this revolution into the field of health and fitness by integrating our products to work seamlessly with Apple iOS devices.”